CONSTRUCTIVE BIO

Serial Number 98771525
Registration 8098578
700

Registration Progress

Application Filed
Sep 26, 2024
Under Examination
Approved for Publication
Nov 25, 2025
Published for Opposition
Nov 25, 2025
Registered
Jan 13, 2026

Trademark Image

CONSTRUCTIVE BIO

Basic Information

Serial Number
98771525
Registration Number
8098578
Filing Date
September 26, 2024
Registration Date
January 13, 2026
Published for Opposition
November 25, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 13, 2026
Registration
Registered
Classes
001 005 040 042

Rights Holder

Constructive Biology Limited

24
Address
27 Old Gloucester Street
London WC1N3AX
GB

Ownership History

Constructive Biology Limited

Original Applicant
24
London GB

Constructive Biology Limited

Owner at Publication
24
London GB

Constructive Biology Limited

Original Registrant
24
London GB

Legal Representation

Attorney
Karen L. Elbing

USPTO Deadlines

Next Deadline
2170 days remaining
Section 8 Declaration Due (Principal Register)
Due Date
January 13, 2032
Grace Period Ends
July 13, 2032

Application History

25 events
Date Code Type Description Documents
Jan 13, 2026 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 13, 2026 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 25, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 25, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 19, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 27, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 27, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 27, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 27, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Oct 27, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Sep 23, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 23, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 23, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 26, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 26, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 26, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 2, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 2, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 2, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 27, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 27, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 27, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 19, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 26, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 26, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Nucleic acid sequences, other than for medical or veterinary purposes; artificial nucleic acid sequences, other than for medical or veterinary purposes; amino acid sequences, other than for medical or veterinary purposes; artificial amino acid sequences, other than for medical or veterinary purposes; enzymes for industrial purposes; enzymes for scientific purposes; proteins for industrial purposes; bacterial preparations for industrial use, other than for medical or veterinary purposes; biopolymers, namely, unprocessed polymers of amino acids and hydroxy acids; biopolymers, namely, unprocessed polymers of amino acids; biopolymers, namely, unprocessed polymers of hydroxy acids; biomolecules, namely amino acids, other than for medical or veterinary purposes; biomolecules, namely hydroxy acids, other than for medical or veterinary purposes; biomolecules, namely amino acids and hydroxy acids, other than for medical or veterinary purposes; bioplastics in the nature of unprocessed plastics that derive from biological sources; synthetic bacteria for use in the manufacture of polymers and materials comprising amino acids; synthetic bacteria for use in the manufacture of polymers and materials comprising hydroxy acids; synthetic bacteria for use in the manufacture of polymers and materials comprising nucleic acid sequences; recoded bacterial genomes, namely, nucleic acid sequences with a modified genetic code that differs from the genetic code of the native species, other than for medical or veterinary purposes; synthetic eukaryotic cells in the nature of mammalian, plant, yeast or other eukaryotic cells with a synthetic genome for scientific, laboratory or medical research; recoded eukaryotic genomes namely, nucleic acid sequences with a modified genetic code that differs from that of the native species, other than for medical or veterinary purposes; reagents for research purposes; bacteriophage-resistant bacteria for biomanufacturing for use in the manufacture of polymers and materials comprising amino acids; bacteriophage-resistant bacteria for biomanufacturing for use in the manufacture of polymers and materials comprising hydroxy acids; bacteriophage-resistant bacteria for biomanufacturing for use in the manufacture of polymers and materials comprising nucleic acid sequences; biochemical preparations in the nature of polypeptides containing non-proteinogenic amino acids for industrial purposes; biochemical preparations in the nature of polypeptides containing non-proteinogenic amino acids for scientific purposes; biochemical preparations in the nature of polypeptides containing non-canonical amino acids for industrial purposes; biochemical preparations in the nature of polypeptides containing non-canonical amino acids for scientific purposes
Class 005
Pharmaceuticals preparations for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders; biotechnological preparations for medical and veterinary use, namely, biotechnological pharmaceutical preparations in the form of fluid extracts for medicinal uses, pills, medicated tablets, compressed medicinal lozenges, elixirs, syrups for medicinal preparations, medicinal cordials, solid extracts, powdered extracts, concentrations, filled capsules and medicinal compounds in solid and liquid form for the treatment of diabetes, diarrhea, fungal infections/conditions, hypertension, inflammation, arthritis, helminth infections, cardiovascular conditions, allergies, dermatological conditions, gynaecological conditions, haematological conditions, metabolic conditions, nausea and vertigo, oncological diseases and disorders, cancer and tumours; biopharmaceuticals for medical and veterinary use, namely, biopharmaceutical preparations for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders; enzymes for medical purposes; enzymes for veterinary purposes; bacterial preparations for medical purposes; bacterial preparations for veterinary purposes; antibodies for medical purposes; antibody-drug conjugates in the nature of antibodies for medical purposes; proteins for medical purposes, namely, for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders, all of the aforesaid being protein based; nucleic acid sequences for medical and veterinary purposes; peptides for medical and veterinary purposes, namely, synthetic peptides for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders, all of the aforesaid being peptide based; polypeptides containing non-proteinogenic amino acids for medical and veterinary purposes namely, synthetic peptides for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders, all of the aforesaid being non-proteinogenic amino acid polypeptide based; polypeptides containing non-canonical amino acids for medical and veterinary purposes namely, synthetic peptides for human and veterinary purposes namely analgesics preparations, antibiotics preparations, pharmaceutical preparations for treating diabetes, antidiarrheals medicines, antifungal preparations, antihypertensives, antihistamines, pharmaceutical preparations for the treatment of inflammation, pharmaceutical preparations for the treatment of arthritis, anthelmintics, cardiovascular agents for medical purposes, allergy medications, dermatologicals, diuretics, animal feed supplements, human growth hormones, animal growth hormones, pharmaceutical preparations for treating gynaecological conditions, pharmaceutical preparations for treating haematological conditions, laxatives, antiendotoxin antibodies for medical purposes, pharmaceutical agents affecting metabolism, pediculicidal shampoos, pharmaceutical preparations for treating nausea and vertigo, sleeping pills/tablets, medical preparations containing stimulants for treating neurological disorders, tranquilisers, psychotherapeutic preparations in the nature of psychotropics, vitamins, pharmaceutical preparations for the treatment of oncological diseases and disorders, preparations for use in the treatment of cancer and tumours, medicinal creams for skin care, pharmaceutical preparations for the treatment of immune system related diseases and disorders, and pharmaceutical preparations for the treatment of endocrine related diseases and disorders, all of the aforesaid being non-canonical amino acid polypeptide based
Class 040
Biomanufacturing for others of nucleic acid sequences, polymers, and materials comprised of amino acids; biomanufacturing for others of nucleic acid sequences, polymers, and materials comprised of hydroxy acids; biomanufacturing for others of nucleic acid sequences, polymers, and materials comprised of amino acids and hydroxy acids; custom manufacture of unnatural and synthetic biomaterials in the nature of nucleic acid sequences, polymers, and/or materials comprised of amino acids; custom manufacture of unnatural and synthetic biomaterials in the nature of nucleic acid sequences, polymers, and/or materials comprised of hydroxy acids; custom manufacture of unnatural and synthetic biomaterials in the nature of nucleic acid sequences, polymers, and/or materials comprised of amino acids and hydroxy acids
Class 042
Scientific research relating to medicines; scientific research relating to proteins and amino acid sequences for industrial and medical purposes; research and development in the pharmaceutical and biotechnology fields; scientific research and development for the pharmaceutical industry; scientific research and development in the field of biomaterials; scientific design and development of nucleic acid sequences, amino acid sequences, enzymes, bacteria, proteins and biomaterials; scientific research in the field of DNA synthesis; scientific research in the field of protein synthesis; DNA sequencing technology research; bioplastics technology research; drug discovery services; research in the field of bioinformatics relating to design and development of nucleic acid sequences, amino acid sequences, enzymes, bacteria, proteins and biomaterials; scientific research relating to genetic code expansion

Classification

International Classes
001 005 040 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
BIO